**Specifications Table**TableSubject areaPharmacologyMore specific subject areaOvarian toxicology and menopausal osteoporosisType of dataImage (TIFF)How data was acquiredSky Scan 1076μCT scanner (Aartselaar, Belgium) and Strength tester (TK-252C/RDT)Data formatanalyzedExperimental factorsVCD was given for 15 days followed by 30 days drug-free treatment for induction of ovotoxicityExperimental featuresAfter induction of ovotoxicity, Letrozole and exemestane alone and in combination with raloxifene were given for 30 days as specified in [Fig. 3](#f0015){ref-type="fig"}Data source locationNew Delhi, India, Latitude 28.644800 & Longitude 77.216721Data accessibilityIn the form TIFF

**Value of the data**•Data highlights the negative effects of letrozole and exemestane alone and in combination with raloxifene on bone strength when tested in femoral diaphysis (cortical bone) after one month of treatment.•Further, no adverse effect of the drugs were observed on bone microarchitecture in lumbar vertebrae of VCD treated mice except in trabecular number that was reduced.•Data provide guidance to researchers regarding extending treatment beyond one month to establish animal models for aromatase inhibitors induced bone loss.

1. Data {#s0005}
=======

1.1. Induction of ovotoxicity {#s0010}
-----------------------------

Although, various researchers in the past have used different doses of VCD ranging from 80 to 320mg/kg for inducing ovotoxicity, we have standardized 160 mg/kg dose for the same in our lab. For inducing ovotoxicity, Swiss strain of female albino mice were treated with 160mg/kg of VCD continuously for 15 days followed by 30 days drug free period [@bib1], [@bib2].

1.2. Effect of aromatase inhibitors (letrozole and exemestane) and raloxifene on mechanical strength of femoral diaphysis in normal and ovotoxic mice {#s0015}
-----------------------------------------------------------------------------------------------------------------------------------------------------

In triple point bending test for bone strength, we have observed no significant changes following aromatase inhibitors either alone or in combination with raloxifene [(Fig. 1)](#f0005){ref-type="fig"}.

1.3. Effect of aromatase inhibitors (letrozole and exemestane) and raloxifene on lumbar vertebrae microarchitecture in normal and ovotoxic mice {#s0020}
-----------------------------------------------------------------------------------------------------------------------------------------------

VCD treated mice showed significant decrease in Tb.N only, whereas no effect was observed in Bv/Tv, Tb.Th, Tb.Pf, Tb.Sp and SMI indicating bone loss in very less extent. One month treatment with letrozole and exemestane did not show any effects on Bv/Tv (%), Tb. N, Tb.Th, Tb.Pf, and Tb Sp. SMI as compared to VCD treated group. One month treatment with letrozole and exemestane alone, however, decreases Tb.N ([Fig. 2](#f0010){ref-type="fig"}).

2. Experimental design, materials and methods {#s0025}
=============================================

2.1. Drug doses and treatment {#s0030}
-----------------------------

Treatment with raloxifene was given at the time of letrozole and exemestane administration for the same period of one month. Control group (0.5% CMC, 2 mg/kg); VCD (160 mg/kg); VCD+L (160 mg/kg+1 mg/kg); VCD+Ex (160 mg/kg+3.25 mg/kg) VLR {160 mg/kg+ (1 mg/kg+15 mg/kg)}; VR (160 mg/kg+15 mg/kg); VER {160 mg/kg+ (3.25 mg/kg+15 mg/kg)}. At the end of the treatment schedule, femur and lumbar vertebrae were harvested and analyzed.

Letrozole (1 mg/kg adopted from previous study, [@bib3], exemestane (3.25 mg/kg translated from clinical dose) and raloxifene (15 mg/kg translated from clinical doses) were used. Femora and lumbar was dissected from the animals after euthanasia, cleaned of soft tissue, and fixed before storage in alcohol ([Fig. 3](#f0015){ref-type="fig"}) .

2.2. Bone microarchitecture and triple point bending test {#s0035}
---------------------------------------------------------

Drugs effects on bone micro architecture was determined by using Micro CT measurements (Sky Scan 1076 m CT scanner, Aartselaar, Belgium) and determination of excised bones was carried out using the Sky Scan 1076μCT scanner (Aartselaar, Belgium). Tissue volume (TV), bone volume (BV), the BV/TV ratio, trabecular number (Tb.N in 1/mm), trabecular thickness (Tb.Th in mm), trabecular spacing (Tb.Sp in mm), connectivity density (Conn. D) and structure model index (SMI) in the fracture area was recorded.

Triple point bending test was performed on femoral diaphysis with the help of a strength tester (TK-252C/RDT) where load, energy and stiffness were recorded ([Fig. 3](#f0015){ref-type="fig"}) .
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![Effect of letrozole, exemestane and raloxifene on triple point bending test of femoral diaphysis in VCD treated mice: Data is represented as mean±SEM and analyzed by one way ANOVA followed by Tukey Kramer multiple comparison test. Cont-Control, VCD-4-vinylcyclohexene diepoxide, L- letrozole, Ex-Exemestane, R-Raloxifene.](gr1){#f0005}

![Effect of letrozole, exemestane and raloxifene on bone microarchitecture of lumbar vertebrae in VCD treated mice: Data is represented as mean±SEM and analyzed by one way ANOVA followed by Tukey Kramer multiple comparison test, \**P*\<0.05. Cont-Control, VCD-4-vinylcyclohexene diepoxide, L- letrozole, Ex-Exemestane, R-Raloxifene.](gr2){#f0010}

![Schematic representation of study design. Female albino mice were made ovotoxic by the administration of VCD 160 mg/kg for 15 days followed by 30 days drug-free period, following which letrozole and exemestane were administered with raloxifene for one month. Lumbar and femur bones were then harvested followed by scanning in micro-CT and triple point bending tests.](gr3){#f0015}
